Table 1.
Cross-sectional adherence |
Time to adherence (TTA) |
|||
---|---|---|---|---|
Patient-level factor | Mt-sDNA tests ordered, N | Mt-sDNA tests completed, N | % | Median (IQR), days |
All eligible study patients | 368,494 | 262,084 | 71.1 | 27 (20, 37) |
Age (y) | ||||
65–69 | 141,191 | 99,764 | 70.7 | 28 (21, 39) |
70–74 | 121,566 | 86,220 | 70.9 | 27 (20, 37) |
75–79 | 70,502 | 50,998 | 72.3 | 25 (20, 35) |
80–85 | 35,235 | 25,102 | 71.2 | 24 (19, 34) |
Gender | ||||
Women | 235,617 | 166,601 | 70.7 | 28 (21, 38) |
Men | 132,806 | 95,433 | 71.9 | 26 (20, 35) |
Medicare coverage type | ||||
Traditional Medicare | 250,800 | 178,922 | 71.3 | 27 (20, 37) |
Medicare advantage | 117,694 | 83,162 | 70.7 | 27 (20, 37) |
Test order date | ||||
September 2016 | 21,429 | 15,276 | 71.3 | 21 (15, 31) |
October 2016 | 23,961 | 16,894 | 70.5 | 24 (18, 34) |
November 2016 | 26,032 | 18,538 | 71.2 | 27 (21, 35) |
December2016 | 23,408 | 16,474 | 70.4 | 29 (21, 41) |
January 2017 | 26,894 | 19,591 | 72.8 | 27 (21, 36) |
February 2017 | 27,161 | 19,821 | 73.0 | 28 (21, 38) |
March 2017 | 34,339 | 24,553 | 71.5 | 28 (22, 37) |
April 2017 | 32,532 | 23,343 | 71.8 | 27 (21, 39) |
May 2017 | 38,921 | 27,674 | 71.1 | 29 (23, 39) |
June 2017 | 37,898 | 26,745 | 70.6 | 26 (20, 37) |
July 2017 | 33,690 | 23,636 | 70.2 | 24 (17, 37) |
August 2017 | 42,229 | 29,539 | 69.9 | 25 (19, 36) |
Mt-sDNA: multi-target stool DNA; TTA: median time to adherence; IQR: interquartile range.